Rosiglitazone Chemische Eigenschaften,Einsatz,Produktion Methoden

R-S?tze Betriebsanweisung:

R36/38:Reizt die Augen und die Haut.

S-S?tze Betriebsanweisung:

S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S37/39:Bei der Arbeit geeignete Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.

Verwenden

Rosiglitazone is an insulin sensitizer; binds to peroxisome proliferator activated receptor gamma (PPAR- γ).

Indications

Rosiglitazone is approved for use as monotherapy and in conjunction with metformin, though it is sometimes combined with a sulfonylurea or insulin. It is usually taken once or twice a day with or without food. Rosiglitazone may cause a modest increase in lowdensity lipoprotein and triglyceride concentrations, but it is unclear whether this effect has any clinical significance or persists in the long term.

Allgemeine Beschreibung

Rosiglitazone is 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, and is availableas the maleate salt in tablets containing the drug alone(Avandia) or in combination products with metformin(Avandamet) or with glimepiride (Avandaryl). The2-aminopyridine moiety allows for salt formation; the marketedformulations contain the 1:1 salt with maleic acid, inwhich the pyridine nitrogen accepts a proton, forming the2-aminopyridinium species.

Clinical Use

Although rosiglitazone is extensively biotransformed—playing the major role in both transformations, and some involvementof CYP2C9.21,47 The sulfate conjugate M10 is thepredominant circulating metabolite by 4-hour postdose. Theextraordinarily high plasma protein binding of this metabolite(and the N-demethylated sulfate conjugate M4) in humans accountsfor the lengthy residence time of the radioactivity in thebody, despite the relatively short pharmacokinetic half-life(4–4.5 hours) of rosiglitazone itself.

Rosiglitazone Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Rosiglitazone Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hebei Weibang Biotechnology Co., Ltd	+8615531157085	abby@weibangbio.com	China	8806	58
Zibo Hangyu Biotechnology Development Co., Ltd	+86-0533-2185556 +8617865335152	Mandy@hangyubiotech.com	China	10986	58
Apeloa production Co.,Limited	+8619933239880	admin@apcl.com.cn	China	861	58
Capot Chemical Co.,Ltd.	+86-（0）57185586718 +86-13336195806	sales@capot.com	China	29793	60
Henan Tianfu Chemical Co.,Ltd.	+86-0371-55170693 +86-19937530512	info@tianfuchem.com	China	21634	55
Hangzhou FandaChem Co.,Ltd.	+8615858145714	FandaChem@Gmail.com	China	8780	55
career henan chemical co	+86-0371-86658258 +8613203830695	sales@coreychem.com	China	29880	58
SHANDONG ZHI SHANG CHEMICAL CO.LTD	+86 18953170293	sales@sdzschem.com	China	2930	58
Biochempartner	0086-13720134139	candy@biochempartner.com	CHINA	965	58
Hubei xin bonus chemical co. LTD	86-13657291602	linda@hubeijusheng.com	CHINA	22963	58

122320-73-4()Verwandte Suche:

---

• 5-(4-[2-(METHYL-PYRIDIN-2-YL-AMINO)-ETHOXY]-BENZYL)-THIAZOLIDINE-2,4-DIONE
• 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]-phenyl]methyl]-2,4-thiazolidine-dione
• ROSIGLITAZONE
• Rosiglitazone free base
• Rosiglitazone and its intermediates
• ROSIGLITAZONE 99%
• RosiglitazoneBase/Hcl/Maleate
• 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzylidine]-2,4-thiazolidinedione
• 5-[[4-[2-(methyl-pyridin-2-yl-amino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione
• BRL 49653
• ROEIGLITAZONEMALEATE
• ROSIGLITAZONEHCL
• ROSIGLIAZONE
• ROSIGLIAZONE (5-{4-[2-(N-methyl-N-2-pyridyl)amino]-ethoxy}benzyl}-2,4-thiazolidinedione)
• 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
• 5-[4-[2-[methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-quinone
• 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-
• (RS)-5-[4-(2-[Methyl(pyridin-2-yl)aMino]ethoxy)benzyl]thiazolidine-2,4-dione
• 50MG/1G/1KG
• Rosiglitazone(BRL 49653)
• roiglitazone
• 2-[(2-benzoylphenyl)aMino]-3-{4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}propanoic acid
• Rosiglitazone (Avandia)
• 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-tiazolidinedione
• Rosiglitazone 5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]-phenyl]methyl]-2,4-thiazolidine-dione
• Rosiglitazone, >=98.5%
• 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
• 5-[[4-[2-[methyl(2-pyridinyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride
• itazone
• Rosig
• Rosiglitazone >
• Rosiglitazone Rosiglitazone
• Rosiglitazone,>98%
• 5-[4-[2-[Methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione
• RosigL
• Rosiglitazone USP/EP/BP
• Rosiglitazone (base,meleate)
• RosiglitazoneQ: What is Rosiglitazone Q: What is the CAS Number of Rosiglitazone Q: What is the storage condition of Rosiglitazone Q: What are the applications of Rosiglitazone
• Rosiglitazone 122320-73-4
• Rosiglitazone Maleate (1605817)
• AVANDIA
• ROSIGLITAZONE HCL
• diabetic,PPAR,neuroprotection,senescence,PPARγ,Inhibitor,cancer,diabetes,Autophagy,BRL 49653,BRL-49653,HCC,antihyperglycemic,TRP Channel,bladder,Rosiglitazone,mellitus,Peroxisome proliferator-activated receptors,inhibit,carcinoma,smoke,Apoptosis,ovarian cancer,Transient receptor potential channels,hepatocellular,Ferroptosis
• Rosiglitazone Monomer
• Rosiglitazone, PPARgamma agonist
• 122320-73-4
• 15141-29-0
• 122320-70-4
• C18H19N3O3S
• AVANDIA
• Inhibitor
• Rosiglitazone
• API's
• Active Pharmaceutical Ingredients